VIRUS-INACTIVATED BLOOD PLASMA OF UNIVERSAL CHANGE RECEIVED FROM PORTIONS OF PLASMA OF NON CAUCASOID RACE INDIVIDUALS Russian patent published in 2009 - IPC A61K35/16 A61P7/02 

FIELD: medicine.

SUBSTANCE: virus-inactivated blood plasma for introduction to the person, in essence, does not contain the agents inactivating viruses, received from donors from whom 10 % or more belong to population of the non-Caucasoid race individuals, thus plasma is received by mixing of blood or blood plasma of A and B groups, it is unessential AB, without adding blood or blood plasmas of the 0 group, and is characterised that it contains: from five to six parts of blood or a blood plasma of the donors having A group of blood, from four to five parts of blood or a blood plasma of the donors having B group of blood, from zero to one part of blood or a blood plasma of the donors having AB group of blood. The pharmaceutical composition for manufacture of a medical product for treatment of deficiencies of factors of coagulation, thrombocytopenic purpura is offered, and for use in a repeated exchange of great volume of plasma. Application a virus-inactivated blood plasma according to the invention for manufacture of a medical product and the way of a virus-inactivated blood plasma manufacture is offered.

EFFECT: rising of efficiency of treatment.

10 cl, 2 ex